A wave of established China-focused fund managers is returning to fundraise through late 2026 and into 2027, as a multi-year industry consolidation reshapes how global capital enters the country’s VC market. 

Our most-read story from Greater China examines how overseas LP commitments to the latest vintage of China-focused VC funds have picked up, driven by Middle Eastern, European, and regional Asian investors. However, overall US dollar liquidity remains far below its historical levels, as US endowments and pension funds largely stay on the sidelines due to ongoing geopolitical friction and a slowing Chinese economy. 

Moving to Southeast Asia, private equity-backed sale processes and other consolidation plays continued to dominate the top stories in September. Creador’s food ingredient business sale, Amartha-BroilerX restructuring and a potential secondary transaction at Asia OneHealthcare were among the most-read stories. We also tracked fundraising milestones by Ikhlas Capital, 3V Partners and Excelsior Capital Vietnam.

From India, the healthcare-focused theme continues to grab headlines. In September, our top stories included updates from Tata Capital Healthcare Fund and Morgan Stanley Private Equity  Asia exploring a deal to merge its portfolio companies Omega Hospitals and ClearMedi Healthcare.

In case you missed these, here are some of the deeply reported top stories that our readers and subscribers loved in September 2026:-

Southeast Asia

Creador’s food ingredient business draws a bevy of investors in potential sale

Savourés describes itself as ASEAN’s first Asian-owned specialty food ingredients platform, providing marinades, sauces, flavours and other ingredient solutions to F&B companies.

PE giants eye slice of TPG’s Asia OneHealthcare ahead of mega IPO

TPG is exploring a secondary trade sale of a part of its holding in the SE Asian hospital operator to gain some liquidity as the timing of its eventual exit following the IPO can be uncertain.

Navis, Dymon Asia roll healthcare assets into latest funds

The deals reflect a strategy that, while not new, is becoming increasingly common among private equity firms in Asia as buyers and sellers struggle to agree on valuations. 

Indonesia’s INA said to have invested in global school operator

The move is seen as part of INA’s broader strategy to build platforms in globally underinvested sectors of the Indonesian economy, including education.

Founder, existing backers increase stake in coffee chain Kopi Kenangan

The secondary transactions are part of the broader funding round, which has attracted interest from institutional investors. 

Indonesian fintech Amartha said to lead BroilerX restructuring

Amartha is understood to be working toward a structure that could involve establishing a new entity to take over a significant portion of BroilerX’s operating business.

Ikhlas Capital expands LP base with $370m second fund

The final size of Ikhlas II is above the firm’s initial target of $300 million, underscoring the growing interest among investors in SE Asia-focused private equity.

Vietnam’s 3V Partners eyes $300m for debut PE fund

The Vietnam Go Global Fund I is targeting a first close of $50-100 million this year, followed by a final close next year. 

Excelsior Capital Vietnam closes second fund at over $170m

ECVP’s second vehicle had attracted commitments from DFIs such as the European Investment Bank, IFC, FMO and Swedfund. 

Blue Pool Capital, others said to have invested in DatViet’s IPO

With DatViet’s listing slated for October 23, the IPO could provide a potential exit opportunity for some of its early investors, including UOB Venture Management and YF Capital. 

Greater China

How global LPs enter China’s VC market as GPs eye $35b fundraise

A large group of China-focused top venture capital fund managers is expected to re-enter the market over the coming months for fundraising campaigns. 

ADIA in talks to lead Primavera’s new fund with ByteDance exposure

The potential transaction would give new investors exposure to two of China’s most closely watched private technology companies.  

India

Morgan Stanley PE Asia explores Omega-ClearMedi merger in India

The move could give Morgan Stanley PE a larger healthcare footprint and help the two businesses expand into new markets while creating greater scale across their oncology operations. 

Tata Capital Healthcare Fund targets to close Fund III by mid-2027

The firm has completed eight exits, including Intas Biopharmaceuticals, Amanta Healthcare, and Sparsh Nephrocare.